Role of angiostatins in diabetic complications

Biomedit︠s︡inskai︠a︡ khimii︠a︡
A A TykhomyrovT V Grinenko

Abstract

Angiogenesis is a process through which new blood vessels form from pre-existing vessels. Angiogenesis is regulated by a number of factors of peptide nature. Disbalance of angiogenic system appears to be the major causative factor contributing vascular abnormalities in diabetes mellitus, resulting in various complications. Angiostatins, which are kringle-containing fragments of plasminogen/plasmin, are known to be powerful physiological inhibitors of neovascularization. In the present review, current literature data on peculiarities of production of angiostatins and their functioning at diabetes mellitus are summarized and analyzed for the first time. Also, role of angiostatins in the pathogenesis of typical diabetic complications, including retinopathies, nephropathies and cardiovascular diseases, is discussed. Data presented in this review may be useful for elaboration of novel effective approaches for diagnostics and therapy of vascular abnormalities in diabetes mellitus.

References

Oct 1, 1992·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·C P PontingS A Cederholm-Williams
Nov 18, 1971·The New England Journal of Medicine·J Folkman
Aug 31, 1993·Biochemical and Biophysical Research Communications·G Y ShiH L Wu
Dec 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J Folkman
Sep 5, 1997·The Journal of Biological Chemistry·Y CaoM Llinás
Jun 27, 1998·Biochemical and Biophysical Research Communications·W R JiP A Trail
Aug 26, 1998·Archives of Dermatological Research·M E FiniR Mohan
Mar 20, 1999·The Journal of Biological Chemistry·P StathakisP J Hogg
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·R CaoY Cao
Feb 9, 2000·Trends in Biochemical Sciences·M A ParryI Bode
Sep 23, 2000·Nature·P Carmeliet, R K Jain
May 5, 2001·Expert Opinion on Pharmacotherapy·R P DanisL Pratt
Jul 20, 2001·Annals of the New York Academy of Sciences·H R Lijnen
Aug 17, 2001·Current Opinion in Ophthalmology·J H ChangD T Azar
May 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Patrizia ScapiniMarco A Cassatella
Jun 14, 2002·Biochemical and Biophysical Research Communications·Paulo Lee HoMaria Leonor Sarno de Oliveira
Nov 29, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Thomas HerrenEdward F Plow
Feb 20, 2003·Circulation·Ryoji KoshidaKirkwood A Pritchard
Apr 8, 2003·Current Medicinal Chemistry. Anti-cancer Agents·Yihai CaoNiina Veitonmäki
May 31, 2003·International Urology and Nephrology·Judy Tan Shumway, Steven R Gambert
Sep 5, 2003·The Journal of Biological Chemistry·Olivier PeyruchaudPhilippe Clezardin
Oct 11, 2003·Biochemical and Biophysical Research Communications·Ya-Huey ChenLi-Wha Wu
Jan 14, 2004·Journal of Thrombosis and Haemostasis : JTH·J H Geiger, S E Cnudde
Mar 23, 2004·Seminars in Thrombosis and Hemostasis·Yihai Cao, Lexun Xue
Apr 13, 2004·American Journal of Physiology. Renal Physiology·David P BasileWilliam M Chilian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Saishin igaku. Modern medicine
S TojoH Shishido
Ceskoslovenská pediatrie
M CermanováL Králiková
L'Année thérapeutique et clinique en ophtalmologie
H Saraux
© 2021 Meta ULC. All rights reserved